What is the lead time for delivery?

The average lead time is one month for both peak and off-peak seasons.

Where is the company located?

The company is located at 9 Yugang Road, Zhengzhou Airport Economic Comprehensive Experimental Zone, Zhengzhou.

What are the main export markets?

We export to North America, South America, Europe, Southeast Asia, Middle East, Africa, East Asia, and Australia.

Ms-Broiler Improver (Da Tai Neng) with GMP ISO Standard

Name: Ms-Broiler Improver (Da Tai Neng) with GMP ISO Standard
Brand: Henan Muxiang Biological Co., Ltd.
SKU: 2081684545

Henan, ChinaHenan Muxiang Biological Co., Ltd.

US$450.00

10 Tons

Product profile

Customization

Available

Certification

ISO

Shape

Powder

Model NO.

Powder

Active Ingredient

Bacillus Subtilis, Clostridium Butyricum

Function

Nutrition Enhancer

Transport Package

Bag

Specification

25kg/bag

Trademark

Moosun

Origin

China

HS Code

2309901000

Production Capacity

Active Ingredient

Key features

ISO Certified Manufacturer: Operates with GMP and ISO standards ensuring high quality and safety.

Dual Active Ingredients: Contains Bacillus Subtilis and Clostridium Butyricum for nutrition enhancement.

Powder Formulation: Designed as a powder for easy mixing and application in feed.

OEM and ODM Services: Custom branding and formulation services available for clients.

Established Manufacturer: Operating since 2004 with 360 employees and 20 R&D engineers.

Global Market Reach: Exports to North America, Europe, Southeast Asia, and other major regions.

Flexible Payment Terms: Accepts LC, T/T, D/P, PayPal, Western Union, and small-amount payments.

Consistent Lead Time: One-month delivery time for both peak and off-peak seasons.

Company profile

Henan Muxiang Biological Co., Ltd.

Henan, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2016-02-01 CertifiedNearest Port: Shanghai Port, Qingdao PortAverage Response Time: ≤11.88h CertifiedTerms of Payment: LC, T/T, D/P, etc.

AI-Powered supplier vetting

SummaryHenan Muxiang Biological Co., Ltd. is a China-based limited-company factory established in 2004, with 360 employees and operations in veterinary pharmaceuticals and animal-health products. The supplier reports seven pharmaceutical production lines, eight vaccine production lines, first-class production and inspection equipment, GMP management, ISO9001:2015 certification, and ISO/CNAS laboratory certification. Its R&D resources include more than 40 core personnel, over 30 of whom hold doctoral or master's degrees, while 21–30 quality-control staff are reported. The company exports to multiple global regions, has self-operated import and export rights, and states a one-month order-fulfillment period in both peak and off-peak seasons. Evidence supports capabilities in certification, innovation, production, and international operations. However, the provided information does not sufficiently establish after-sales service performance, financial credibility, customization execution, or specific customer cases.

Supplier typeThe supplier is identified as a limited company and a factory in the manufacturing industry, with its operating location in Henan, China. This indicates a direct manufacturing entity rather than only a trading or intermediary business.

CertificationsThe supplier reports a systematic GMP management system, ISO/CNAS laboratory international certification, and an ISO9001:2015 certificate. These stated certifications and quality systems provide explicit evidence of formal quality-management capability.

R&D capabilityThe supplier reports more than 40 core R&D personnel, including over 30 doctors or master's degree graduates, 20 years of preparation-technology experience among R&D engineers, and advanced R&D platforms such as a National Enterprise Technology Center, National Postdoctoral Research Station, and Academician Workstation. It also reports improving herbal active-ingredient extraction by more than 30% versus a traditional process, supporting a strong stated innovation profile.

Production capacityThe supplier reports seven pharmaceutical production lines and eight vaccine production lines, first-class production and inspection equipment, six production lines in a separate operational data field, and one-month order fulfillment in both peak and off-peak seasons. Although the line-count figures are not fully consistent across the slices, the evidence clearly supports substantial pharmaceutical and vaccine manufacturing capability.